Top Buy
| Security | Buy | Sell | Buy (1W) ▲ | Sell (1W) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Sarepta Therapeutics | 1 | 0 | 0 | 0 | €133.50 | €130.00 | -2.622% |
| Viatris Inc. | 1 | 0 | 0 | 0 | €10.88 | - | - |
| Biocryst Pharmaceuticals | 8 | 0 | 0 | 0 | €6.43 | €11.13 | 73.132% |
| Adaptimmune Therapeutics PLC ADR | 2 | 0 | 0 | 0 | €1.19 | €2.00 | 68.067% |
| Fagron N.V. | 1 | 0 | 0 | 0 | €19.76 | €20.00 | 1.215% |
| TG Therapeutics Inc. | 19 | 2 | 0 | 0 | €16.96 | €26.00 | 53.309% |
| Sanofi S.A. ADR | 10 | 0 | 0 | 0 | €48.00 | €55.25 | 15.113% |
| MorphoSys AG | 7 | 0 | 0 | 0 | €67.40 | €65.00 | -3.561% |
| Emergent Biosolutions Inc. | 4 | 3 | 0 | 0 | €9.26 | - | - |
| Eledon Pharmaceuticals Inc. | 6 | 0 | 0 | 0 | €2.60 | €12.21 | 369.650% |
| AstraZeneca plc | 2 | 0 | 0 | 0 | €149.15 | €165.00 | 10.627% |
| Bayer AG | 15 | 3 | 0 | 0 | €27.33 | €45.00 | 64.684% |
| Knight Therapeutics | 1 | 0 | 0 | 0 | €3.72 | €10.00 | 168.817% |
| Adverum Biotechnologies Inc. | 9 | 0 | 0 | 0 | €1.38 | €20.55 | 1388.986% |
| ProQR Therapeutics N.V. | 8 | 2 | 0 | 0 | €1.68 | €3.03 | 80.297% |
| Xenon Pharmaceuticals Inc. | 1 | 1 | 0 | 0 | €39.80 | €50.00 | 25.628% |
| Acadia Pharmaceuticals | 29 | 1 | 1 | 0 | €17.20 | €31.78 | 84.845% |
| QIAGEN NV | 12 | 0 | 1 | 0 | €40.47 | €47.52 | 17.415% |
| Innoviva Inc. | 6 | 0 | 1 | 0 | €17.20 | €30.00 | 74.419% |
| Agios Pharmaceuticals Inc. | 9 | 1 | 1 | 0 | €40.40 | €48.75 | 20.667% |
| Actinium Pharmaceuticals Inc. | 3 | 0 | 1 | 0 | €5.67 | €8.50 | 49.912% |
| Incyte Corp. | 13 | 2 | 1 | 0 | €59.08 | €77.67 | 31.468% |
| Esperion Therapeutis.Inc. | 16 | 1 | 1 | 0 | €1.88 | €10.00 | 430.926% |
| Sanofi S.A. | 4 | 0 | 1 | 0 | €97.07 | €100.00 | 3.018% |
| Pfizer Inc. | 28 | 4 | 1 | 0 | €27.88 | €41.51 | 48.897% |